Over the last 10 years, the age-adjusted incidence of diabetes mellitus (DM) in the United States has doubled, and recent estimates suggest that by the year 2030, approximately 439 million individuals worldwide will be affected by this chronic disease. The increasing global epidemic of diabetes implies an associated increase in rates of vascular complications from this chronic disease, including diabetic retinopathy (DR). Despite advances in diagnosis and management of ocular disease in diabetic patients, eye complications from diabetes continue to be the leading cause of vision loss and new onset blindness in working-age individuals throughout the United States.
|Effective start/end date||1/1/19 → 12/31/23|
- Jaeb Center for Health Research (Agmt 10.24.2019//2UG1EY014231-18)
- Kennedy Institute - National Eye Clinic (Agmt 10.24.2019//2UG1EY014231-18)